AstraZeneca's new pill, baxdrostat, could help millions with hard-to-control high blood pressure.

AstraZeneca's new daily pill, baxdrostat, shows promise in treating hard-to-control high blood pressure. In clinical trials, the drug reduced blood pressure by 9-10 mmHg, potentially helping up to 10 million in the UK and half a billion globally. Baxdrostat targets aldosterone, a hormone regulating blood pressure and salt levels. AstraZeneca plans to file it with regulators this year.